Change in HbA1c Across the Baseline HbA1c Range in Type 2 Diabetes Patients Receiving Once-Weekly Dulaglutide Versus Other Incretin Agents
Crossref DOI link: https://doi.org/10.1007/s13300-019-0625-3
Published Online: 2019-05-04
Published Print: 2019-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gentilella, Raffaella
Romera, Irene
Nicolay, Claudia
Buzzetti, Raffaella
Vázquez, Luis Alberto
Sesti, Giorgio
Text and Data Mining valid from 2019-05-04
Version of Record valid from 2019-05-04
Article History
Received: 9 January 2019
First Online: 4 May 2019